statistiche ricercatore

Continente	#
NA - Nord America	1.301
EU - Europa	724
AS - Asia	662
SA - Sud America	90
AF - Africa	24
OC - Oceania	3
Continente sconosciuto - Info sul continente non disponibili	1
Totale	2.805

Nazione	#
US - Stati Uniti d'America	1.271
IT - Italia	238
SG - Singapore	196
VN - Vietnam	158
CN - Cina	131
DE - Germania	113
RU - Federazione Russa	105
BR - Brasile	76
HK - Hong Kong	69
GB - Regno Unito	51
IN - India	49
SE - Svezia	44
IE - Irlanda	35
FR - Francia	26
CA - Canada	20
FI - Finlandia	18
ES - Italia	13
DK - Danimarca	12
NL - Olanda	12
UA - Ucraina	12
ID - Indonesia	10
ET - Etiopia	9
PL - Polonia	9
RO - Romania	9
TR - Turchia	8
AT - Austria	6
KR - Corea	6
MX - Messico	6
ZA - Sudafrica	6
IR - Iran	5
JP - Giappone	5
EG - Egitto	4
GE - Georgia	4
VE - Venezuela	4
AR - Argentina	3
AU - Australia	3
BA - Bosnia-Erzegovina	3
BE - Belgio	3
CO - Colombia	3
IQ - Iraq	3
NG - Nigeria	3
TH - Thailandia	3
AE - Emirati Arabi Uniti	2
AL - Albania	2
BD - Bangladesh	2
BG - Bulgaria	2
CH - Svizzera	2
EC - Ecuador	2
JO - Giordania	2
LT - Lituania	2
MD - Moldavia	2
MY - Malesia	2
PK - Pakistan	2
RS - Serbia	2
CL - Cile	1
DO - Repubblica Dominicana	1
DZ - Algeria	1
EU - Europa	1
HU - Ungheria	1
JM - Giamaica	1
KE - Kenya	1
KG - Kirghizistan	1
NI - Nicaragua	1
NP - Nepal	1
PA - Panama	1
PH - Filippine	1
PT - Portogallo	1
PY - Paraguay	1
SA - Arabia Saudita	1
SK - Slovacchia (Repubblica Slovacca)	1
UZ - Uzbekistan	1
Totale	2.805

Nome	#
Two novel SCN5A loss-of-function mutations affect patients with severe arrhytmogenic syndromes	378
Effect of the ketogenic diet in excitable tissues	373
Modulation of the intrinsic neuronal excitability by multifunctional liposomes tailored for treatment of Alzheimer’s disease	358
Gabapentin treatment in a patient with KCNQ2 developmental epileptic encephalopathy	317
Progressive epileptic encephalopathy associated with a novel HCN2 mutation	307
Channelopathies and epileptic syndromes: characterization of novel variants associated with progressive epileptic encephalopathy and in vitro validation of therapeutic approaches	307
Caveolin-3 and Caveolin-1 Interaction Decreases Channel Dysfunction Due to Caveolin-3 Mutations	262
Innovative therapies and nanomedicine applications for the treatment of alzheimer’s disease: A state-of-the-art (2017–2020)	255
HCN1 novel mutations in familiar generalized epilepsy	214
A novel de novo HCN2 loss-of-function variant causing developmental and epileptic encephalopathy treated with a ketogenic diet	189
Totale	2.960

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	304	0	0	0	0	0	47	49	59	38	36	34	41
2021/2022	197	33	38	30	21	6	9	11	12	5	7	4	21
2022/2023	249	22	80	29	19	21	36	4	9	18	3	4	4
2023/2024	270	4	11	8	27	46	55	18	23	25	12	5	36
2024/2025	567	34	60	39	24	52	29	29	30	57	91	48	74
2025/2026	837	244	65	98	221	188	21	0	0	0	0	0	0
Totale													2.960

Bicocca Open Archive